A Review Of lenmeldy
The FDA assessed the safety and performance of atidarsagene autotemcel dependant on details from 37 young children who acquired atidarsagene autotemcel in two solitary-arm, open-label medical trials and in an expanded accessibility program.[7] Children who received therapy with atidarsagene autotemcel were as compared to untreated little ones (norm